Stifel Financial
SCMP

Stifel Financial’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Stifel Financial’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,465
Closed -$206K – 2829
2017
Q4 		$206K Sell
11,465
-295
-3% -$3.63K ﹤0.01% 2426
2017
Q3 		$141K Sell
11,760
-465
-4% -$5.22K ﹤0.01% 2437
2017
Q2 		$131K Buy
+12,225
New +$125K ﹤0.01% 2429

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Stifel Financial's SCMP Position: Q1 2018 in Review

Stifel Financial sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 11,465 shares — an estimated $206K sold.

Stifel Financial first reported a position in SCMP in Q2 2017 and held it in 3 quarters. The position peaked at $206K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Stifel Financial reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Stifel Financial sold 11,465 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $206K.
  • Stifel Financial first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2017 and held it in 3 quarters.
  • Stifel Financial's Sucampo Pharmaceuticals, Inc. position peaked at $206K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Stifel Financial's 13F filing for Q1 2018, filed 11 May 2018.